Detalles de la búsqueda
1.
Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354.
Bioorg Med Chem Lett
; 24(19): 4708-4713, 2014 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25176330
2.
Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
Mol Pharmacol
; 83(4): 781-92, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23307185
3.
Regulatory Support Improves Subsequent IRB Approval Rates in Studies Initially Deemed Not Ready for Review: A CTSA Institution's Experience.
J Empir Res Hum Res Ethics
; 13(2): 139-144, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29345179
4.
Development of a Series of (1-Benzyl-3-(6-methoxypyrimidin-3-yl)-5-(trifluoromethoxy)-1H-indol-2-yl)methanols as Selective Protease Activated Receptor 4 (PAR4) Antagonists with in Vivo Utility and Activity Against γ-Thrombin.
J Med Chem
; 59(16): 7690-5, 2016 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27482618
5.
Synthesis of indole derived protease-activated receptor 4 antagonists and characterization in human platelets.
PLoS One
; 8(6): e65528, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23776495
6.
Response to Commentary: Regulatory Support Improves Subsequent IRB Approval Rates in Studies Initially Deemed Not Ready for Review-A CTSA Institution's Experience.
J Empir Res Hum Res Ethics
; 13(2): 148, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29345186
7.
Reactivity of the C2'-oxidized abasic lesion and its relevance to interactions with type I base excision repair enzymes.
Chem Res Toxicol
; 19(3): 463-8, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16544953
Resultados
1 -
7
de 7
1
Próxima >
>>